Sign In
Buy GRFS
$7.18
-0.100 (-1.37%)
At Close: Jun 23, 2026
GRFS or ZTS: Which Is the Better Value Stock Right Now?
12:40pm, Wednesday, 14'th Feb 2024
Investors with an interest in Medical - Drugs stocks have likely encountered both Grifols (GRFS) and Zoetis (ZTS). But which of these two stocks offers value investors a better bang for their buck rig
Here's Why Grifols (GRFS) Is a Great 'Buy the Bottom' Stock Now
10:56am, Monday, 05'th Feb 2024
Grifols (GRFS) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a tre
GRFS or ZTS: Which Is the Better Value Stock Right Now?
12:46pm, Monday, 29'th Jan 2024
Investors interested in stocks from the Medical - Drugs sector have probably already heard of Grifols (GRFS) and Zoetis (ZTS). But which of these two stocks presents investors with the better value op
Spanish supervisor analysing Grifols' response to Gotham City report
07:05am, Tuesday, 23'rd Jan 2024
Spanish stock market supervisor said on Tuesday it is analysing the response from drugmaker Grifols to the allegations in a report from short-seller Gotham City which questioned its financial accounts
Grifols to respond "very, very soon", before deadline, to supervisor request - board member
09:29am, Friday, 19'th Jan 2024
Grifols will send "very, very soon" its responses to a query made by Spain's CNMV stock market supervisor, in advance of reaching a ten-day deadline that expires next week, Grifols' board member Tomas
S&P keeps Grifols at 'B+', sees leverage decreasing in 2024
09:15am, Friday, 19'th Jan 2024
Ratings agency S&P on Friday kept its 'B+' rating for Grifols , with a stable outlook for 2024, in a boost for the Spanish pharmaceutical company after a report by short-seller Gotham City Research se
Exclusive: ECB sounds out lenders on exposure to Spanish drugmaker Grifols - sources
01:14pm, Wednesday, 17'th Jan 2024
The European Central Bank has asked some lenders to detail their exposure to Spain's Grifols and its related entities, after the drugmaker was last week accused of manipulating its financial accounts
Here's Why Grifols (GRFS) is Poised for a Turnaround After Losing -31.55% in 4 Weeks
11:19am, Monday, 15'th Jan 2024
Grifols (GRFS) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates c
Grifols says Haier Group still OK to buy stake in Shanghai RAAS
03:07pm, Sunday, 14'th Jan 2024
Spanish pharma company Grifols said on Sunday evening Chinese home appliance maker Haier Group still plans to close the acquisition of a 20% stake in Shanghai RAAS Blood Products as announced in late
GRFS vs. ZTS: Which Stock Is the Better Value Option?
12:47pm, Friday, 12'th Jan 2024
Investors looking for stocks in the Medical - Drugs sector might want to consider either Grifols (GRFS) or Zoetis (ZTS). But which of these two stocks presents investors with the better value opportun
Grifols: Wait And See For Now
01:15pm, Wednesday, 10'th Jan 2024
Gotham City's recent allegations against Grifols have caused GFRS stock to significantly decline. Our team at Mare will remain waiting for clarifications. We expect the company's stock to be under pre
10 Things to Know as Gotham City Slams Grifols (GRFS) Stock in New Short Report
11:24am, Tuesday, 09'th Jan 2024
Shares of Spanish pharmaceutical company Grifols (NASDAQ: GRFS ) are plunging lower following the publication of a short report from Gotham City Research. The research firm has alleged that Grifols ha
Spanish market supervisor says it makes no sense to query Grifols accounts
09:28am, Tuesday, 09'th Jan 2024
The head of the Spanish CNMV stock market supervisor Rodrigo Buenaventura said it made no sense to question the integrity of the audited accounts of drugmaker Grifols or to ignore a report on Tuesday
Spanish blood plasma company stock tumbles after short-seller research report
08:24am, Tuesday, 09'th Jan 2024
Spanish blood plasma company Grifols saw its shares plunge more than 40% at one point on Tuesday after hedge fund Gotham City Research questioned the Madrid-listed group's financial reporting.
Grifols to hold board meeting Tuesday afternoon after Gotham City report
06:24am, Tuesday, 09'th Jan 2024
Spanish pharmaceutical company Grifols is set to hold a board meeting on Tuesday afternoon in reaction to a report from Gotham City Research questioning the company's accounting released earlier, boar
